97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details

臨床試験数 : 2,527 / 薬物数 : 1,465 - (DrugBank : 259) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

32 trials found

diseases per page:

Showing 1 to 10 of 32 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05186623 (ClinicalTrials.gov)	February 5, 2022	22/12/2021	Prediction Model for Response to Biologics and Small Molecular Agent for UC	Establishment of Prediction Model of Biologics and Small Molecular Agent for Patients With Ulcerativ ...	Ulcerative Colitis	Drug: Vedolizumab , Ustekinumab, or Tofacitinib	Asan Medical Center	NULL	Recruiting	18 Years	79 Years	All	300		Korea, Republic of
2	EUCTR2020-004457-76-PL (EUCTR)	28/10/2021	15/09/2021	A Long-term Extension Study of Ustekinumabin Pediatric Participants with different medical condition ...	A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumabin Pediatric Cli ...	Paediatric conditions in - Moderately to Severely Active Crohn's Disease - Moderately to Severely Ac ...	Trade Name: STELARA ® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab O ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	France;United States;Argentina;Poland;Turkey;Russian Federation;Japan
3	JPRN-jRCT2041200098	28/10/2021	02/02/2021	A Study of Ustekinumabin Pediatric Participants with Moderately to Severely Active Ulcerative Coliti ...	A Phase 3 Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumabas Openlabel Intravenous ...	Colitis, Ulcerative	-UstekinumabDose Based on BSA and Body Weight As per BSA and body weight Ustekinumabwill be administe ...	Nishikawa Kazuko	NULL	Recruiting	>= 2age old	< 18age old	Both	90	Phase 3	United States Of America;Belgium;Germany;Hungary;Poland;Russian Federation;United Kingdom Of Great B ...
4	NCT04963725 (ClinicalTrials.gov)	July 18, 2021	8/7/2021	A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumabin Japane ...	Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumabin Japanese Clinical ...	Ulcerative Colitis	Drug: Ustekinumab	Janssen Pharmaceutical K.K.	NULL	Recruiting	16 Years	N/A	All	140		Japan
5	NCT04372108 (ClinicalTrials.gov)	June 24, 2021	30/4/2020	A Study to Assess the Long-Term Safety of UstekinumabVersus Other Biologics in Patients With Crohn's ...	An Observational Study to Assess the Long-term Safety of UstekinumabVersus Other Biologic Therapies ...	Crohn Disease;Colitis, Ulcerative	Drug: Ustekinumab;Drug: Other Biologic Therapies	Janssen Scientific Affairs, LLC	NULL	Recruiting	18 Years	N/A	All	1056		United States
6	NCT04630028 (ClinicalTrials.gov)	March 17, 2021	13/11/2020	A Study of Ustekinumabin Pediatric Participants With Moderately to Severely Active Ulcerative Coliti ...	A Phase 3 Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumabas Open-label Intravenous ...	Colitis, Ulcerative	Drug: Ustekinumab Dose Based on BSA and Body Weight;Drug: Matching Placebo	Janssen Research & Development, LLC	NULL	Recruiting	2 Years	17 Years	All	90	Phase 3	United States;Belgium;Germany;Hungary;Japan;Poland;Russian Federation;United Kingdom
7	EUCTR2019-004224-38-DE (EUCTR)	25/02/2021	20/10/2020	A Clinical Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumabas Intravenous Induction ...	A Phase 3 Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumabas Open-label Intravenous ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Trade Name: STELARA ® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab O ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 3	United States;Hungary;Poland;Belgium;Russian Federation;Germany;United Kingdom;Japan
8	JPRN-jRCT1031200329	28/01/2021	28/01/2021	UC Bio Study	Open-ravel randomized control trial to evaluate the efficacy of biologics for ulcerative colitis wit ...	Ulcerative colitis Biologics;D003093	Infliximab:Infliximab(5 mg / kg / body weight) is infused intravenously at 0, 2, 6, 14, and 22 weeks ...	Naganuma Makoto	NULL	Recruiting	>= 16age old	Not applicable	Both	231	N/A	Japan
9	EUCTR2019-004224-38-HU (EUCTR)	30/12/2020	22/10/2020	A Clinical Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumabas Intravenous Induction ...	A Phase 3 Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumabas Open-label Intravenous ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Trade Name: STELARA ® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab O ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 3	United States;Hungary;Poland;Belgium;Russian Federation;Germany;United Kingdom;Japan
10	EUCTR2019-004652-11-SI (EUCTR)	28/08/2020	31/08/2020	A Study of Etrolizumab-Based Induction Therapy Combinations Followed by Etrolizumab Maintenance Ther ...	RANDOMIZED, OPEN-LABEL PHASE 3B STUDY OF ETROLIZUMAB BASED INDUCTION THERAPY COMBINATIONS FOLLOWED B ...	Ulcerative Colitis (UC) MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerativ ...	Product Name: Etrolizumab Product Code: RO5490261/F04-02 INN or Proposed INN: Etrolizumab Other descrip ...	F. Hoffmann-La Roche Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	372	Phase 3	Serbia;United States;Slovakia;Spain;Ukraine;Ireland;Israel;Russian Federation;Italy;Switzerland;Fran ...

First Previous1 2 3 4Next Last